How much does the Bangladeshi generic version of Dasatinib (Stardasad) cost?

Dasatinib (Dasatinib) is an oral targeted therapy drug, a tyrosine kinase inhibitor, mainly used to treat patients with chronic myelogenous leukemia (CML) and some acute lymphoblastic leukemia (ALL).

Dasatinib (Dasatinib) is now on the market in China and has been included in the medical insurance system. Patients can purchase it directly in China, with the price ranging from RMB 4,000 to RMB 5,000. For specific drug pricing and medical insurance reimbursement ratios, patients are asked to go to the pharmacy of their local hospital for detailed consultation.

In addition, the price of foreigndasatinib (Stardas) generic drugs is relatively more affordable and has a significant price advantage compared with domestic drugs. Among them, the generic drug of Dasatinib (Stardaxel) from Bangladesh Beacon Pharmaceutical is a generic drug that is officially marketed abroad, and the price is about 1,000 yuan.

It is worth noting that the ingredients of original drugs marketed in China and foreign generic drugs are highly consistent. Therefore, when patients choose drugs, they can make reasonable choices based on their actual situation and economic conditions.

Dasatinib blocks the proliferation and survival of abnormal leukemia cells by inhibiting the activity of specific tyrosine kinases, specifically BCR-ABL fusion protein kinases and other receptor tyrosine kinases. BCR-ABL is the main disease-causing gene of CML and Ph+ ALL. The therapeutic effect of dasatinib (Stardasid) is mainly achieved by inhibiting the kinase activity of BCR-ABL.

Dasatinib (Startase) is approved for the treatment of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) in adult patients and children, specifically those with Ph+ CML or Ph+ ALL.

Dasatinib (Startase) is mainly metabolized by the liver, andCYP3A4is its main metabolic pathway. MostDasatinib and its metabolites are excreted in the bile and to a small extent in the urine. Because dasatinib metabolism is affected by enzymes such as CYP3A4, there may be interactions with other drugs that affect these enzymes, resulting in changes in drug concentrations.

Dasatinib may cause a series of adverse reactions, including nausea, vomiting, diarrhea, fatigue, edema, rash, headache, hypertension, anemia, etc. Serious adverse reactions may include liver damage, cardiac arrhythmia, bleeding and infection. Patients should closely monitor adverse reactions during use of Dasatinib and inform their doctors in a timely manner.